Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole

William R Miller, Alexey Larionov

Association between the spread of circulating tumor cells and breast cancer subtypes

Xiaowei Qi, Xinhua Yang, Linjun Fan, Yi Zhang, Fan Zhang, Jun Jiang

Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer

Cristina Cadenas, Dennis Franckenstein, Marcus Schmidt, Mathias Gehrmann, Matthias Hermes, Bettina Geppert, Wiebke Schormann, Lindsey J Maccoux, Markus Schug, Anika Schumann, Christian Wilhelm, Evgenia Freis, Katja Ickstadt, J？rg Rahnenführer, J？rg I Baumbach, Albert Sickmann, Jan G Hengstler

Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study

Deirdre P Cronin-Fenton, Lars Pedersen, Timothy L Lash, S？ren Friis, John A Baron, Henrik T S？rensen

Controversies in the hormonal adjuvant therapy of postmenopausal patients

M Dowsett

Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes

Lorenzo Melchor, Laura Paula Saucedo-Cuevas, Iván Mu？oz-Repeto, Socorro María Rodríguez-Pinilla, Emiliano Honrado, Alfredo Campoverde, Jose Palacios, Katherine L Nathanson, María José García, Javier Benítez

Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients

Galatea Kallergi, Harris Markomanolaki, Vicky Giannoukaraki, Maria A Papadaki, Areti Strati, Evi S Lianidou, Vassilis Georgoulias, Dimitris Mavroudis, Sofia Agelaki

Epithelial to mesenchymal transition and breast cancer

Eva Tomaskovic-Crook, Erik W Thompson, Jean Thiery

Key signalling nodes in mammary gland development and cancer: Myc

Nancy E Hynes, Tina Stoelzle

Correction: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

Olafur Stefansson, Jon Jonasson, Oskar Johannsson, Kristrun Olafsdottir, Margret Steinarsdottir, Sigridur Valgeirsdottir, Jorunn Eyfjord

Increased levels of active c-Src distinguish invasive from in situ lobular lesions

Donghui Zou, Han-Seung Yoon, Ahmad Anjomshoaa, David Perez, Ryuji Fukuzawa, Parry Guilford, Bostjan Humar

Resident macrophages influence stem cell activity in the mammary gland

David E Gyorki, Marie-Liesse Asselin-Labat, Nico van Rooijen, Geoffrey J Lindeman, Jane E Visvader

Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women

Carolyn J Crandall, Mary E Sehl, Sybil L Crawford, Ellen B Gold, Laurel A Habel, Lesley M Butler, MaryFran R Sowers, Gail A Greendale, Janet S Sinsheimer

MicroRNA expression profiling of male breast cancer

Matteo Fassan, Raffaele Baffa, Juan P Palazzo, Joshua Lloyd, Marco Crosariol, Chang-Gong Liu, Stefano Volinia, Hannes Alder, Massimo Rugge, Carlo M Croce, Anne Rosenberg

Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort

Christy G Woolcott, Gertraud Maskarinec, Christopher A Haiman, Martijn Verheus, Ian S Pagano, Lo？c Le Marchand, Brian E Henderson, Laurence N Kolonel

Molecular heterogeneity of breast cancer: implications for treatment and clinical trial design

L Pusztai

Clinical utility and future of genetic profiles for breast cancer

C Hudis

Does magnetic resonance imaging alter the clinical management of patients with breast cancer? A three year single centre experience

H Khan, MM Hoosein, AN Khan, M Al-Attar

Magnetic resonance imaging for diagnosis, staging, and follow-up

M Morrow

Axillary staging: new approaches and treatment of minimal disease

MTFD Vrancken Peeters

Adjuvant therapy of HER2+ breast cancer

EP Winer

Pathological features and patterns of metastatic disease in locally advanced inflammatory and non-inflammatory breast cancer

MZ Mvere, SJ Tennant, AJ Evans, I Ellis, J James, M Shehat, S Chan

Mammographic density

Norman F Boyd, Lisa J Martin, Martin Yaffe, Salomon Minkin

Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?

Ian E Smith

Bisphosphonates in the adjuvant treatment of early breast cancer

M Gnant

Controversies in hormonal adjuvant therapy for premenopausal patients

A Howell

An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ

Fariba Behbod, Frances S Kittrell, Heather LaMarca, David Edwards, Sofia Kerbawy, Jessica C Heestand, Evelin Young, Purna Mukhopadhyay, Hung-Wen Yeh, D Craig Allred, Min Hu, Kornelia Polyak, Jeffrey M Rosen, Daniel Medina

Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study

Sanaz A Jansen, Suzanne D Conzen, Xiaobing Fan, Erica J Markiewicz, Gillian M Newstead, Gregory S Karczmar

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S Finn, Judy Dering, Dylan Conklin, Ondrej Kalous, David J Cohen, Amrita J Desai, Charles Ginther, Mohammad Atefi, Isan Chen, Camilla Fowst, Gerret Los, Dennis J Slamon

BU-32: a novel proteasome inhibitor for breast cancer

Joseph K Agyin, Bindu Santhamma, Hareesh B Nair, Sudipa S Roy, Rajeshwar R Tekmal

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study

Szu-Min Hsieh, Maxime P Look, Anieta M Sieuwerts, John A Foekens, Kent W Hunter

Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer

Günther Weber, Clara Chamorro, Fredrik Granath, Annelie Liljegren, Sami Zreika, Zuzana Saidak, Bengt Sandstedt, Samuel Rotstein, Romuald Mentaverri, Fabio Sánchez, Andor Pivarcsi, Mona St？hle

Correction: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1

Hans Neubauer, Susan E Clare, Wojciech Wozny, Gerhard P Schwall, Slobodan Poznanovic, Werner Stegmann, Ulrich Vogel, Karl Sotlar, Diethelm Wallwiener, Raffael Kurek, Tanja Fehm, Michael A Cahill

The multiplex bead array approach to identifying serum biomarkers associated with breast cancer

Byoung Kim, Jong Lee, Pil Park, Yong Shin, Won Lee, Kyung Lee, Sena Ye, Heesun Hyun, Kyung Kang, Donghwa Yeo, Youngdai Kim, Sung Ohn, Dong Noh, Chul Kim

Loss of TGF-β or Wnt5a results in an increase in Wnt/β-catenin activity and redirects mammary tumour phenotype

Kevin Roarty, Sarah E Baxley, Michael R Crowley, Andra R Frost, Rosa Serra

Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents

Michael Untch, Gunter von Minckwitz

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

Catherine Alix-Panabières, Jean-Pierre Vendrell, Monique Slijper, Olivier Pellé, Eric Barbotte, Grégoire Mercier, William Jacot, Michel Fabbro, Klaus Pantel

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer

Frank Wiesmann, Jürgen Veeck, Oliver Galm, Arndt Hartmann, Manel Esteller, Ruth Knüchel, Edgar Dahl

Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression

Cecilia Williams, Luisa Helguero, Karin Edvardsson, Lars-Arne Haldosén, Jan-？ke Gustafsson

Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice

Marina Simian, Mina J Bissell, Mary Barcellos-Hoff, Gopalan Shyamala

Phosphoinositide 3-kinase targeting by the β galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death

Valerie Wells, Livio Mallucci

Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm

Benita Tan, Gek Lim, Kamila Czene, Per Hall, Kee Chia

Transforming growth factor-β in breast cancer: too much, too late

Mary Barcellos-Hoff, Rosemary J Akhurst

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

Gwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, Pascal Finetti, Thomas Moreau, Benjamin Esterni, Daniel Birnbaum, Fran？ois Bertucci, Christian Chabannon

Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis

Johanna R Reed, Ronald P Leon, Majken K Hall, Kathryn L Schwertfeger

Triple-negative breast cancers are increased in black women regardless of age or body mass index

Lesley A Stead, Timothy L Lash, Jerome E Sobieraj, Dorcas D Chi, Jennifer L Westrup, Marjory Charlot, Rita A Blanchard, John C Lee, Thomas C King, Carol L Rosenberg

Gene expression profiling of the tumor microenvironment during breast cancer progression

Xiao-Jun Ma, Sonika Dahiya, Elizabeth Richardson, Mark Erlander, Dennis C Sgroi

Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry

Jason A Zell, Walter Y Tsang, Thomas H Taylor, Rita S Mehta, Hoda Anton-Culver

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705